KR0133553B1 - 뇌기능 개선제 - Google Patents

뇌기능 개선제

Info

Publication number
KR0133553B1
KR0133553B1 KR1019910700073A KR910700073A KR0133553B1 KR 0133553 B1 KR0133553 B1 KR 0133553B1 KR 1019910700073 A KR1019910700073 A KR 1019910700073A KR 910700073 A KR910700073 A KR 910700073A KR 0133553 B1 KR0133553 B1 KR 0133553B1
Authority
KR
South Korea
Prior art keywords
group
lower alkyl
compound
brain function
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019910700073A
Other languages
English (en)
Korean (ko)
Other versions
KR920700645A (ko
Inventor
야스후미 시라사끼
신이찌로 아시다
Original Assignee
모리다 다까가즈
산뗑세이야꾸 가부시끼가이샤
스즈끼 다다시
다이이찌 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리다 다까가즈, 산뗑세이야꾸 가부시끼가이샤, 스즈끼 다다시, 다이이찌 세이야꾸 가부시끼가이샤 filed Critical 모리다 다까가즈
Publication of KR920700645A publication Critical patent/KR920700645A/ko
Application granted granted Critical
Publication of KR0133553B1 publication Critical patent/KR0133553B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
KR1019910700073A 1989-06-16 1990-06-14 뇌기능 개선제 Expired - Fee Related KR0133553B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP153646/89 1989-06-16
JP15364689 1989-06-16
PCT/JP1990/000773 WO1990015607A1 (en) 1989-06-16 1990-06-14 Drug for improving brain function

Publications (2)

Publication Number Publication Date
KR920700645A KR920700645A (ko) 1992-08-10
KR0133553B1 true KR0133553B1 (ko) 1998-04-23

Family

ID=15567085

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910700073A Expired - Fee Related KR0133553B1 (ko) 1989-06-16 1990-06-14 뇌기능 개선제

Country Status (8)

Country Link
US (1) US5182276A (enExample)
EP (1) EP0429676B1 (enExample)
KR (1) KR0133553B1 (enExample)
AT (1) ATE142881T1 (enExample)
CA (1) CA2032487A1 (enExample)
DE (1) DE69028603T2 (enExample)
DK (1) DK0429676T3 (enExample)
WO (1) WO1990015607A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0429676T3 (enExample) * 1989-06-16 1997-03-10 Santen Pharmaceutical Co Ltd
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists
RU2123330C1 (ru) * 1997-04-02 1998-12-20 Фармацевтическая фирма "Здоровье" Способ получения таблетированной формы препарата
EA019020B1 (ru) * 2011-07-12 2013-12-30 Институт Химических Проблем Им. М.Ф. Нагиева Национальной Академии Наук Азербайджана Способ лечения нарушений гемостаза при ушибах головного мозга
JP2025525514A (ja) * 2022-07-14 2025-08-05 シャンハイ、レイジング、ファーマシューティカル、カンパニー、リミテッド Ｔｐｋアゴニスト及びそれを用いた神経変性疾患の治療方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166554A (en) * 1965-01-19 Certificate of correction
US3715353A (en) * 1970-10-12 1973-02-06 Squibb & Sons Inc (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS59148771A (ja) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
DE3347173A1 (de) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPS60166674A (ja) * 1984-02-09 1985-08-29 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
AU5511986A (en) * 1985-03-19 1986-10-13 Santen Pharmaceutical Co. Ltd. 2-arylbenzothiazine derivatives
ATE71622T1 (de) * 1985-07-29 1992-02-15 Santen Pharmaceutical Co Ltd Neue benzothiazinabkoemmlinge.
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
DE3614355A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Neue benzothiazinon-derivate, verfahren zu ihrer herstellung , sie enthaltende arzneimittel und deren verwendung
DE3614363A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPS6357578A (ja) * 1986-08-27 1988-03-12 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
JPH068284B2 (ja) * 1986-08-27 1994-02-02 参天製薬株式会社 ３−チオキソ−ベンゾチアジン誘導体
JPS63104969A (ja) * 1986-10-23 1988-05-10 Santen Pharmaceut Co Ltd 含硫黄複素環化合物
DK0429676T3 (enExample) * 1989-06-16 1997-03-10 Santen Pharmaceutical Co Ltd

Also Published As

Publication number Publication date
DE69028603T2 (de) 1997-02-13
WO1990015607A1 (en) 1990-12-27
EP0429676A4 (en) 1992-05-20
EP0429676B1 (en) 1996-09-18
DE69028603D1 (de) 1996-10-24
ATE142881T1 (de) 1996-10-15
KR920700645A (ko) 1992-08-10
DK0429676T3 (enExample) 1997-03-10
US5182276A (en) 1993-01-26
EP0429676A1 (en) 1991-06-05
CA2032487A1 (en) 1990-12-17

Similar Documents

Publication Publication Date Title
US5929061A (en) Method for treating vascular headaches
JPH0643299B2 (ja) 薬剤療法
SK13862001A3 (sk) Použitie zlúčeniny pri výrobe liečivá na liečenie neurologických alebo neuropsychiatrických porúch
US5023244A (en) Anti-dementia agents
AU2019382168A1 (en) A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
US20200289510A1 (en) Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing
IE843149L (en) Synergistic pharmaceutical compositions
KR20010032009A (ko) 수면성 무호흡의 치료에 미타자핀을 사용하는 방법
CN101757624B (zh) 一种预防和治疗老年痴呆症的组合物
US5182276A (en) Nootropic agent
KR101695801B1 (ko) 운동 뉴런의 자가 포식 작용 억제를 위한 약학적 조성물 및 이의 용도
KR102935431B1 (ko) 디아미노피리미딘 화합물을 사용하여 자궁내막증-관련 통증 치료 방법
HUT71497A (en) New pharmaceutical use of 1,2,3,4,4a,5,10,10a-octahydro-benzo(g) quinoline derivatives
AU2004275852A1 (en) Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
JPH0466477B2 (enExample)
DE60035162T2 (de) Ein ZNS-penetrierender NK-1-Rezeptor-Antagonist in Kombination mit einem antidepressiven oder einem anxiolytischen Wirkstoff zur Behandlung von Depression und Angst
US20060183921A1 (en) Pharmaceutically active compounds and methods of use
US4464377A (en) Anti-thrombotic therapeutic compositions
BRPI0809937A2 (pt) Métodos de potencialização de tratamento de radioterapia, de intensificação da radiossensibilidade e de diminuição da proliferação de população de células e de tratamento do crescimento de tumor
KR100350156B1 (ko) 혈관확장제로간질환및관련증상을치료하는방법 및 이에 사용되는 조성물
WO1999004783A1 (en) Composition for protection from damage by ischemia
IL145696A (en) Use of melatonin antagonists in the preparation of pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders
US4246277A (en) Lowering the concentration of plasma triglycerides
JPWO1990015607A1 (ja) 脳機能改善薬
US3746714A (en) Methods for inhibiting aggressive behavior by means of s-triazolo-(3,4-a)-isoquinolines

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20001223

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20001223

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000